Data

FDA Responds to Ladapo’s Letter Over DNA Fragments in mRNA Vaccines: ‘Quite Implausible’

The Food and Drug Administration issued a response to Florida Surgeon General Matthew Ladapo's letter claiming there were DNA fragments present in the mRNA COVID-19 vaccines.

Privacy Policy for AmericanFaith.com

We are committed to protecting your privacy. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our...

Rising Cost of Living, Housing Crisis Causing Immigrants To Leave Canada in Mass Amounts

Due to the high cost of living and rental shortages, emigration numbers in Canada are rising at a rapid pace.

AI Firm to End Partnership With Chinese Companies

An artificial intelligence firm announced that it will end its partnership with Chinese companies following the United States issuing security concerns.

More Than 150 Chinese Illegal Immigrants Enter California With Luggage

A group of Chinese illegal immigrants entered the United States from Jacumba Hot Springs, California.

Healthcare Worker Turned Whistleblower Faces Court After Exposing Deaths Linked to COVID Vaccine

56-year-old healthcare worker turned whistleblower of Te Whatu Ora, New Zealand's public health agency, Barry Young, was arrested over the weekend for his alleged involvement in the "unauthorized disclosure and misuse of data."

Tom Cotton Introduces Plan to Ban Importation of Chinese Seafood into the U.S.

Sen. Tom Cotton (R-AR) will introduce a new bill this week to ban the United States from importing seafood and aquaculture products from China.

Masking Children Failed to Show ‘Real World Effectiveness’

A study from the British Medical Journal (BMJ) found that masking children failed to show any "real world effectiveness."

Air Force Studies Cancers for Service Members Who Worked With Nuclear Weapons

The Air Force is conducting a study on the correlation between service members who have worked with nuclear missiles in the past and the high rate of cancer.

Pfizer Halts Weight Loss Pill After Study Shows ‘High Rates’ of Adverse Side Effects

Pfizer announced last week that it is discontinuing development of its twice-daily weight loss pill "danuglipron" after a clinical trial showed "high rates" of adverse side effects among users.

Latest news

- Advertisement -spot_img